Abstract
Two hundred thirteen patients with malignant melanoma who underwent resection with curative intent were studied retrospectively at the Massachusetts General Hospital, and a group at high risk of recurrence was identified. The patients were classified by pathologic criteria utilizing Clark’s levels. All of the patients in this group had lesions of levels III, IV, or V with vertical thickness exceeding 1.5 mm [2, 3] and/or metastases to regional lymph nodes. This corresponds to stage II of the 1977 American Joint Commission For Cancer Staging and End Results Reporting. The observed recurrence rate in this group of patients was 25% at 1 year and 50% at 5 years. Many of these patients had distant metastases without evidence of local failure. This finding strongly suggests, though it does not prove, the presence of subclinical metastatic disease at the time of initial surgical treatment. The concept of clinically undetectable micrometastases with an important role for adjuvant treatment with chemotherapy is exemplified in the treatment of other solid tumors, notably carcinoma of the breast.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Reference
Beretta, G.: Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in Stage I–II malignant melanoma: Preliminary report. In: Immunotherapy of cancer. Present status of trials in man. Terry, W. D., Windhorst, D. (eds.). New York: Raven Press 1978.
Breslow, R.: Tumor thickness, level of invasion and node dissection in Stage I cutaneous melanoma. Ann. Surg. 182, 572 (1975).
Clark, W. M. (Jr.), From, L., Bernadino, E. A., Mihm, M. C.: The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 29, 705 (1969).
Cox, D. R.: Regression models and life tables (with discussion). J. R. Statist. Soc. B 34, 187 (1972).
Cutler, S. F., Ederer, F.: Maximum utilization of the life table method in analyzing survival. J. Chronic. Dis. 8, 699 (1958).
Eilber, F. R., Holmes, E. C., Morton, D. L.: Immunotherapy as an adjunct to surgery in the treatment of cancer. World J. Surg. 1, 547 (1977).
Eilber, F. R., Holmes, E. C., Ramming, K. P., Sparks, F. C., Morton, D. L.: Adjuvant immunotherapy of Stage II malignant melanoma. N.E.J.M. 294, 237 (1976).
Eilber, F. R., Morton, D. L., Holmes, E. C., Sparks, F. C. et al.: Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma. N.E.J.M. 294, 237 (1976).
Gutterman, J. U., Mavligit, G., Gotlieb, J. A., Burgess, M. A. et al.: Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus Calmette-Guerin. N.E.J.M. 291, 592 (1974).
Gutterman, J. U., Mavligit, G. M., McBride, C., Frei, E. et al.: Active immunotherapy with BCG for recurrent malignant melanoma. Lancet 1973/I, 208.
Hill, G. J., Grage, J. B., Minton, J. P., Krementz, E. T. et al.: DTIC-melanoma randomized surgical adjuvant study. A.S.C.O. Abs. 1007 (1975).
Mantel, N.: Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemother. Rep. 50, 163 (1966).
Mastrangelo, M. J., Bellet, R. E., Berkelhammer, J., Clark, W. H. (Jr.): Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases. Cancer 36, 1305 (1975).
McIllmurray, M. B., Embleton, M. J., Reeves, W. C., Langman, M. J. S. et al.: Controlled trial of active immunotherapy in management of Stage II-B malignant melanoma. Br. Med. J. 1977/I, 540.
McKelvey, E. M., Luce, J. K., Talley, R. W., Hersh, E. M. et al.: Combination chemotherapy with Bis chloroethyl nitrosurea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma. Cancer 39, 1 (1977).
McKelvey, E. M., Luce, J. K., Vaitkevicius, V. K., Talley, R. W. et al.: Bis chloroethyl nitrosurea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma. Cancer 39, 5 (1977).
Morton, D. L., Eilber, F. R., Malmgren, R. A., and Wood, W. C.: Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery 68, 158 (1970).
Nathanson, L.: Regression of intradermal malignant melanoma after intralesional injection of mycobacterium bollis strain BCG. Cancer Chemother. Rep. 56, 659 (1972).
Pinsky, C., Hirshaut, Y., Oestgen, H.: Treatment of malignant melanoma by intralesional injection of BCG. Proc. Am. Assoc. Cancer Res. 13, 21 (1972).
Pinsky, C. M., Hirshaut, Y., Wanebo, W. J., Fortner, J., et al.: Surgical adjuvant immunotherapy in patients with malignant melanoma: A prospective, randomized trial. In: Immunotherapy of cancer Present status of trials in man. Terry, W. D., Windhorst, D. (eds.). New York: Raven Press 1978.
Seigler, H. F., Shingleton, W. W., Metzgar, R. S., Buckley, C. E. et al.: Nonspecific and specific immunotherapy in patients with melanoma. Surgery 72, 162 (1972).
Sparks, F. C., Silverstein, M. J., Hunt, J. S., Morton, D. L.: Complications of BCG immunotherapy in patients with cancer. N.E.J.M. 289, 827 (1973).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Kaufman, S.D., Cosimi, A.B., Wood, W.C., Carey, R.W. (1979). Adjuvant Therapy in Malignant Melanoma: A Trial of Immunotherapy, Chemotherapy, and Combined Treatment. In: Bonadonna, G., Mathé, G., Salmon, S.E. (eds) Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II. Recent Results in Cancer Research, vol 68. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81332-0_57
Download citation
DOI: https://doi.org/10.1007/978-3-642-81332-0_57
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81334-4
Online ISBN: 978-3-642-81332-0
eBook Packages: Springer Book Archive